This lecture provides the advanced practice practitioner with an overview of the pediatric conditions leading to a neurogenic bladder, a review of the management of these patients and the key issues relevant to successfully transitioning these patients (and their families) to an adult practice. Developmental issues, pharmacological treatments and recommended routines are addressed.
Contact hours available until 11/3/2016.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:
Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation
Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab
Speaker disclosures:
Valre Welch, MSN, CPNP
Consultant: Holister Continence Care Clinical Advisory Board
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Objectives:
• Discuss etiologies of a neurogenic bladder in pediatric patient.
• List 2 developmental tasks of adolescence.
• Recognize 2 management issues in the young adult with a neurogenic bladder.